Aptt and pt high means

Reading File

Finding Sources

Searching Images

coagulation cascade PT aPTT pathway diagram

Reading File

Here is a complete, structured answer:

Both aPTT and PT Elevated - What It Means

Understanding What Each Test Measures

Test	Pathway Tested	Factors Involved
PT (Prothrombin Time)	Extrinsic + Common pathway	VII, X, V, II (prothrombin), I (fibrinogen)
aPTT (Activated Partial Thromboplastin Time)	Intrinsic + Common pathway	XII, XI, IX, VIII, X, V, II, I

When both are elevated, the problem lies in the common pathway (factors I, II, V, X) or there is a combined/global defect affecting multiple pathways.

Causes of Both PT and aPTT Being High

1. Disseminated Intravascular Coagulation (DIC) - #1 Cause

Massive activation of coagulation consumes all clotting factors
Both PT and aPTT are prolonged
Also see: low fibrinogen, low platelets, elevated D-dimer/FDPs
Triggered by: sepsis, trauma, malignancy, obstetric emergencies, pancreatitis

2. Liver Failure / Liver Disease

The liver makes most coagulation factors (I, II, V, VII, IX, X, XI)
Both PT and aPTT are prolonged because factor synthesis is globally impaired
Conventional PT/aPTT tests do NOT fully capture coagulation in cirrhosis (rebalanced hemostasis)

3. Vitamin K Deficiency (severe)

Vitamin K is needed for factors II, VII, IX, X (and proteins C and S)
Mild deficiency: PT elevated first (factor VII shortest half-life)
Severe deficiency: both PT and aPTT elevated

4. Massive Transfusion / Dilutional Coagulopathy

Replacing blood volume with packed RBCs dilutes clotting factors
Both tests prolonged

5. Heparin Overdose (unfractionated heparin at high doses)

Normally prolongs aPTT more, but at high doses prolongs both

6. Warfarin/Coumadin Overdose

Normally prolongs PT first, but in overdose affects both

7. Coagulation Factor Inhibitors

Autoantibodies (e.g., acquired inhibitors to Factor V, Factor X)
Lupus anticoagulant (typically prolongs aPTT more, but can affect both)
Suspected when mixing studies fail to correct the prolonged times

8. Common Pathway Factor Deficiencies

Isolated deficiencies of Factor I (afibrinogenemia), Factor II, Factor V, or Factor X
Rare hereditary conditions

Quick Diagnostic Approach

Both PT & aPTT elevated?
        |
        ├─ Check platelet count + D-dimer + fibrinogen
        |        Low platelets + high D-dimer + low fibrinogen → DIC
        |
        ├─ Check liver function tests (AST, ALT, albumin, bilirubin)
        |        Abnormal → Liver failure
        |
        ├─ Check vitamin K status / nutritional history
        |        Poor nutrition, antibiotics, malabsorption → Vit K deficiency
        |
        ├─ Mixing study (patient plasma + normal plasma 1:1)
        |        Corrects → Factor deficiency
        |        Does NOT correct → Inhibitor (lupus anticoagulant, anti-factor Ab)
        |
        └─ Check medications (heparin, warfarin, direct anticoagulants)

Key Mnemonics

"Both prolonged = Common pathway problem or global failure"
Major causes: DIC, Liver disease, Vitamin K deficiency (severe)

Sources: Henry's Clinical Diagnosis and Management by Laboratory Methods; Miller's Anesthesia, 10e; Morgan & Mikhail's Clinical Anesthesiology, 7e

How much vitk

Finding Sources

Reading File

Here is a complete breakdown of Vitamin K dosing across all clinical situations:

Vitamin K (Phytonadione) Dosing

1. Warfarin Reversal (Adults)

INR / Clinical Status	Dose & Route
INR < 4.5, no bleeding	Just hold warfarin - no Vit K needed
INR 4.5-10, no bleeding, high bleed risk	2.5 mg oral
INR > 10, no bleeding	5 mg oral
Any INR + active/major bleeding	10 mg IV (over 30 min) + 4F-PCC or FFP
Life-threatening bleeding	10 mg IV + 4F-PCC 50 U/kg (max 5000 U)

IV Vitamin K must be given as a slow infusion over 20-30 min - never rapid bolus (risk of anaphylaxis). Oral route is preferred over subcutaneous (SC absorption is erratic).

2. Warfarin Reversal (Pediatric - Harriet Lane)

INR / Bleeding	Weight <40 kg	Weight ≥40 kg
INR 4.5-10, no bleed	0.03 mg/kg PO	1-2.5 mg PO
INR ≥10, no bleed	0.06 mg/kg PO	5-10 mg PO
Minor bleeding	0.03 mg/kg PO	1-2.5 mg PO
Sig. / life-threatening bleed	Vit K IV 0.5-2.5 mg + FFP or PCC	5-10 mg IV + FFP/PCC

3. Vitamin K Deficiency (Not warfarin-related)

Condition	Dose
General deficiency (adults)	10 mg/day IV or IM until correction
Biliary obstruction/fistula	10 mg/day parenterally
Pre-op correction (surgical patients)	10-20 mg/day IV or IM until surgery
Liver disease (child/adolescent)	2.5-5 mg/24 hr PO
Cholestasis (child/adolescent)	2.5-15 mg/24 hr PO

4. Neonatal / Newborn

Indication	Dose
Prophylaxis (routine at birth)	1 mg IM single dose
Hemorrhagic disease of newborn (treatment)	1-2 mg IV/IM

Expected Response Times

Route	PT/INR starts improving
Oral	24-48 hours
IV	12-14 hours
SC	Unpredictable - not recommended

Key Points

Vitamin K corrects factors II, VII, IX, X (and proteins C & S) - all vitamin K-dependent
Does NOT work in liver failure if the liver cannot synthesize factors - need FFP/PCC instead
After high-dose Vit K (e.g. 10 mg), patient may become warfarin-resistant for up to 1 week

Sources: Rosen's Emergency Medicine; Harriet Lane Handbook, 23rd ed.; Goodman & Gilman's Pharmacological Basis of Therapeutics; Pye's Surgical Handicraft

This is a shared conversation. Sign in to Orris to start your own chat.